SNSE/ABBVCL (SNSE/ABBVCL)

Santiago Stock Exchange: SNSE/ABBVCL · CLP

CLP 285,100

+7550.00 (+2.7%)· Recorded snapshot

Market cap	497T
Revenue (ttm)	59.3T
Net income (ttm)	5.8T
EPS (ttm)	CLP 3,490
P/E (trailing)	81.7x
P/E (forward)	19.1x
Dividend	CLP 6,367 (2.23%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 59.3T
Net income (ttm): 5.8T
EPS (ttm): CLP 3,490
P/E (trailing): 81.7x
P/E (forward): 19.1x
Market cap: 497T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E19.1

P25 n/aP50 n/aP75 n/a

Trailing P/E81.7

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC17.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SNSE/ABBVCL indicators

Market & fundamental data

Available fields

221

Groups with data

Currency

USD

Showing 221 of 221 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CLP
Country	United States
Country code	CL
Earnings date	2026-10-30
Employees	57,000
Employees change	5,000
Employees growth	10%
Enterprise value	CLP 560.2T
Exchange	Santiago Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2012
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	US00287Y1091
Last earnings date	2026-07-31
Last refreshed	2026-10-28
Market cap	CLP 497T
Next earnings date	2026-10-30
Price	CLP 285,100.00
Price currency	CLP
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-27
Symbol	snse/ABBVCL
Website	https://www.abbvie.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	41.3x
Average P/E ratio (3Y)	81.44x
Average P/E ratio (5Y)	58.76x
Earnings yield	1.22%
EV/Earnings	96.98x
EV/EBIT	24.92x
EV/EBITDA	18.31x
EV/FCF	33.39x
EV/Sales	8.86x
FCF / EV yield	2.99%
FCF yield	3.38%
Forward P/E	19.06x
Lynch fair value	CLP 16,567.50
Lynch upside	-94.19%
P/(FCF - SBC) ratio	31.3x
P/(OCF - SBC) ratio	29.11x
P/E ratio	81.68x
P/FCF ratio	29.63x
P/OCF ratio	27.66x
P/S ratio	8.38x
Price/EBITDA ratio	17.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	35.56%
EBITDA margin	47.78%
Effective tax rate	27.39%
FCF margin	26.43%
Gross margin	72.79%
Operating margin	35.56%
Pretax margin	13.51%
Profit margin	9.8%
Profit per employee	CLP 101.3M
Profitable quarters	6
Profitable years	17
Revenue per employee	CLP 1B
ROA	10.51%
ROA (5Y)	8.68%
ROCE	24.49%
ROE (5Y)	1,295.17%
ROIC	17.7%
ROIC (5Y)	21.99%
SBC / revenue	1.52%
Tax / revenue	3.7%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	68.54%
EPS growth (Q)	290.39%
EPS growth (QoQ)	422.72%
EPS growth 10Y	0.21%
EPS growth 3Y	-10.05%
EPS growth 5Y	-0.92%
EPS growth quarters	1
EPS growth years	0
FCF growth	-0.16%
FCF growth (Q)	-36.24%
FCF growth (QoQ)	-12.63%
FCF growth 3Y	-9.78%
FCF growth 5Y	-1.43%
Gross profit growth	12.78%
Gross profit growth (Q)	14.64%
Gross profit growth 3Y	5.88%
Gross profit growth 5Y	5.07%
Net income growth	67.69%
Net income growth (Q)	285.18%
Net income growth (QoQ)	424.16%
Net income growth 3Y	-10.12%
Net income growth 5Y	-1.02%
Net income growth quarters	1
Net income growth years	0
OCF growth	1.16%
OCF growth (Q)	-33.32%
OCF growth (QoQ)	-10.26%
OCF growth 10Y	9.1%
OCF growth 3Y	-8.59%
OCF growth 5Y	-0.94%
Operating income growth	21.17%
Operating income growth (Q)	17.54%
Operating income growth 3Y	3.56%
Operating income growth 5Y	3.75%
Revenue growth	10.39%
Revenue growth (Q)	10.16%
Revenue growth (QoQ)	13.25%
Revenue growth 10Y	10.03%
Revenue growth 3Y	4.75%
Revenue growth 5Y	3.69%
Revenue growth quarters	10
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CLP -1.2T
Depreciation and amortization	CLP 7.8T
EBIT	CLP 21.1T
EBITDA	CLP 28.3T
EPS	CLP 3,490.29
Financing cash flow	CLP -11.9T
Free cash flow	CLP 16.8T
Free cash flow minus SBC	CLP 15.9T
Gross profit	CLP 43.2T
Income taxes	CLP 2.2T
Investing cash flow	CLP -6T
Net borrowing	CLP 412.2B
Net cash flow	CLP 94B
Net income	CLP 5.8T
Operating cash flow minus SBC	CLP 17.1T
Operating income	CLP 21.1T
Revenue	CLP 59.3T
Stock-based compensation	CLP 899.2B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.42
Book value per share	CLP -3,094.34
Debt / EBITDA	2.28
Debt / FCF	3.89
Goodwill	CLP 35T
Interest coverage	7.85
Long-term assets	CLP 91.3T
Long-term liabilities	CLP 88.8T
Net cash (debt)	CLP -59.3T
Net cash / market cap	-11.92%
Net debt / EBITDA	2.09
Net debt / FCF	3.53
Piotroski F-Score	8
Property, plant and equipment	CLP 5.7T
Shareholders' equity	CLP -5.4T
Tangible book value	CLP -83.5T
Tangible book value per share	CLP -47,232.63
Total assets	CLP 124.5T
Total cash	CLP 6.1T
Total debt	CLP 65.3T
Total liabilities	CLP 129.9T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.47
Current assets	CLP 33.2T
Current liabilities	CLP 41.1T
Current ratio	0.81
Inventory turnover	3.47
Net working capital	CLP -5.7T
Quick ratio	0.49
Working capital	CLP -7.3T
Working capital turnover	-6,420.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.03%
Dividend growth	-0.52%
Dividend growth years	2
Dividend payment date	2026-11-16
Dividend payment years	4
Dividend payout frequency	Quarterly
Dividend per share	CLP 6,366.78
Dividend yield	2.23%
Ex-dividend date	2026-10-15
Last dividend	CLP 1,707.18
Payout ratio	189.83%
Shareholder yield	2.21%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CLP 205,943.47
1D price change	2.72%
1M price change	13.23%
1M total return	13.96%
1W price change	5.95%
1W total return	5.95%
1Y price change	66.15%
1Y return CAGR	71.9%
1Y total return	71.84%
20-day SMA	CLP 266,940.50
200-day SMA	CLP 197,355.10
3M price change	20.6%
3M total return	21.37%
50-day SMA	CLP 251,131.80
50-day SMA vs 200-day SMA	50over200
52-week high	CLP 285,100.00
52-week high date	2026-10-27
52-week low	CLP 171,590.00
52-week low date	2026-07-20
6M price change	66.15%
6M total return	68.79%
All-time high	CLP 285,100.00
All-time high date	2026-10-27
All-time low	CLP 165,000.00
All-time low date	2025-04-21
Average true range (ATR)	CLP 1,807.42
Average volume	0
Change from 52-week high	0%
Change from 52-week low	66.15%
Change from all-time high	0%
Change from all-time low	72.79%
Monthly RSI	95.76
Previous close	CLP 277,550.00
Price vs 150-day SMA	38.44%
Price vs 20-day SMA	6.8%
Price vs 200-day SMA	44.46%
Price vs 50-day SMA	13.53%
Relative volume	2,000
RSI	95.07
Sharpe ratio	1.41
Sortino ratio	7.69
Weekly RSI	84.89
YTD price change	66.15%
YTD total return	71.84%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.8B
Shares change (QoQ)	-0.23%
Shares change (YoY)	0.03%
Shares held by insiders	0.07%
Shares held by institutions	76.58%
Short ratio	3.2 days

Deeper analysis on SNSE/ABBVCL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SNSE/ABBVCL report

Is a complete SNSE/ABBVCL research report available?

No complete published report is available for snse/ABBVCL (SNSE/ABBVCL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SNSE/ABBVCL (SNSE/ABBVCL)

Price

Financial snapshot

Fair-value bridge

Latest news · SNSE/ABBVCL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SNSE/ABBVCL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SNSE/ABBVCL

Frequently asked questions